Arl4c Promotes the Growth and Drug Resistance of Pancreatic Cancer by Regulating Tumor-Stromal Interactions

Researchers examined the proliferation and drug resistance effect of ADP-ribosylation factor like-4c (Arl4c) on pancreatic cancer cells. They explored the contribution of Arl4c high expression in pancreatic stellate cell activation.